Engineering Vascularized Cardiac Muscle

工程血管化心肌

基本信息

项目摘要

DESCRIPTION (provided by applicant): Our current inability to vascularize and perfuse thick cell masses has hindered efforts to engineer many types of functional tissues including, most critically, cardiac muscle. To serve as a graft for myocardial repair, an engineered cardiac construct must be thick and compact, contain physiologic density of differentiated cells, and contract synchronously in response to electrical stimulation. In addition, the graft must have a capability to integrate with the host vasculature in order to maintain the viability and function of transplanted cells. We propose to engineer functional vascularized myocardium by integrating and advancing our ongoing efforts in the areas of cardiac tissue engineering (MIT) and vascular tissue engineering (Duke). We hypothesize that the cultivation of cardiac myocytes and endothelial cells on specialized scaffolds (highly porous, biodegradable, elastic, with an array of channels) in a bioreactor with medium perfusion and electrical stimulation will promote functional assembly of synchronously contractile engineered muscle. We further hypothesize that vascularization in vitro will enhance the graft capacity for survival, integration and function in vivo. In order to test these hypotheses, which have been derived from two lines of our previous investigations, we propose studies with the following Specific Aims: (1) High density culture of cardiac myocytes on channeled scaffolds with medium perfusion and electrical stimulation, (2) Tissue engineering of a vascularized network, and (3) Tissue engineering and functional characterization of a vascularized cardiac muscle. The effects of perfusion and electrical stimulation on the progression of endothelial cell and myocyte assembly into a synchronously contractile myocardium will be studied in vitro and in vivo (implantation onto a left ventricle in an adult rat model of infarction). Tissue structure and function will be characterized at various hierarchical scales (molecular, structural, functional) and the obtained experimental and modeling data will be used to tailor the conditions and duration of cultivation and engineer implantable grafts. As such, the current proposal is a blueprint for the generation of vascularized cardiac muscle suitable for implantation into injured myocardium.
描述(由申请人提供): 我们目前无法使厚细胞团血管化和灌注,这阻碍了工程设计许多类型的功能组织的努力,其中最关键的是心肌。为了作为心肌修复的移植物,工程化的心脏构造必须厚且紧凑,包含分化细胞的生理密度,并且响应于电刺激而同步收缩。此外,移植物必须具有与宿主脉管系统整合的能力,以维持移植细胞的活力和功能。我们建议通过整合和推进我们在心脏组织工程(MIT)和血管组织工程(杜克)领域的持续努力来工程化功能性血管化心肌。我们假设,培养心肌细胞和内皮细胞的专用支架(高度多孔,可生物降解,弹性,与一系列的通道)在一个生物反应器中与介质灌注和电刺激,将促进同步收缩工程肌肉的功能组装。我们进一步假设,体外血管化将提高移植物的生存能力,整合和功能在体内。为了验证这些假设,这已经从我们以前的两条线的调查,我们提出了以下具体目标的研究:(1)高密度培养心肌细胞的通道支架与介质灌注和电刺激,(2)组织工程的血管化网络,和(3)组织工程和功能表征的血管化心肌。将在体外和体内研究灌注和电刺激对内皮细胞和肌细胞组装成同步收缩心肌进展的影响(植入成年大鼠梗死模型的左心室)。组织结构和功能将在各种层次尺度(分子,结构,功能)进行表征,获得的实验和建模数据将用于定制培养和工程植入移植物的条件和持续时间。因此,目前的建议是一个蓝图的血管化心肌适合植入到受伤的心肌的产生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gordana Vunjak-Novakovic其他文献

Gordana Vunjak-Novakovic的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gordana Vunjak-Novakovic', 18)}}的其他基金

Tissue Engineering Resource Center
组织工程资源中心
  • 批准号:
    10213718
  • 财政年份:
    2020
  • 资助金额:
    $ 33.78万
  • 项目类别:
Tissue Engineering Resource Center-Treatment of COVID-19 induced acute respiratory distress by inhalation of exosomes
组织工程资源中心-吸入外泌体治疗COVID-19引起的急性呼吸窘迫
  • 批准号:
    10164179
  • 财政年份:
    2020
  • 资助金额:
    $ 33.78万
  • 项目类别:
Cancer patient on a chip
芯片上的癌症患者
  • 批准号:
    10646186
  • 财政年份:
    2020
  • 资助金额:
    $ 33.78万
  • 项目类别:
Cancer patient on a chip
芯片上的癌症患者
  • 批准号:
    10210239
  • 财政年份:
    2020
  • 资助金额:
    $ 33.78万
  • 项目类别:
Cancer patient on a chip
芯片上的癌症患者
  • 批准号:
    10417097
  • 财政年份:
    2020
  • 资助金额:
    $ 33.78万
  • 项目类别:
Tissue Engineering Resource Center
组织工程资源中心
  • 批准号:
    10213713
  • 财政年份:
    2019
  • 资助金额:
    $ 33.78万
  • 项目类别:
Tissue Engineering Resource Center
组织工程资源中心
  • 批准号:
    9793664
  • 财政年份:
    2019
  • 资助金额:
    $ 33.78万
  • 项目类别:
Tissue Engineering Resource Center
组织工程资源中心
  • 批准号:
    10627044
  • 财政年份:
    2019
  • 资助金额:
    $ 33.78万
  • 项目类别:
Tissue Engineering Resource Center
组织工程资源中心
  • 批准号:
    10213717
  • 财政年份:
    2019
  • 资助金额:
    $ 33.78万
  • 项目类别:
Tissue Engineering Resource Center
组织工程资源中心
  • 批准号:
    10213712
  • 财政年份:
    2019
  • 资助金额:
    $ 33.78万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.78万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.78万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.78万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 33.78万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 33.78万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 33.78万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 33.78万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 33.78万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 33.78万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 33.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了